Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Litchfield Hills analysts initiated coverage on NextPlat Corp (NASDAQ:NXPL) with a Buy rating on June 24, 2026. Market Context NextPlat Corp operates in the…
Read moreRating Change Barclays analysts initiated coverage on SAB Biotherapeutics, Inc. (NASDAQ:SABS) with a Overweight rating on June 24, 2026. Market Context SAB Biotherapeutics, Inc.
Read moreRating Change Citigroup analysts reiterated a Neutral rating on Ecovyst Inc. (NYSE:ECVT) on June 24, 2026. Market Context Ecovyst Inc.
Read moreRating Change Evercore ISI Group analysts initiated coverage on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) with a Outperform rating on June 24, 2026. Market Context PROCEPT…
Read moreRating Change Barclays analysts reiterated a Overweight rating on 10x Genomics, Inc. (NASDAQ:TXG) on June 24, 2026. Market Context 10x Genomics, Inc.
Read moreRating Change Stifel analysts reiterated a Buy rating on Power Integrations, Inc. (NASDAQ:POWI) on June 24, 2026. Market Context Power Integrations, Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on ACM Research, Inc. (NASDAQ:ACMR) on June 24, 2026. Market Context ACM Research, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Northern Trust Corporation (NASDAQ:NTRSO) on June 24, 2026. Market Context Northern Trust Corporation…
Read moreRating Change Stephens & Co. analysts upgraded Varonis Systems, Inc. (NASDAQ:VRNS) from Equal-Weight to Overweight on June 24, 2026.
Read moreRating Change Wedbush analysts reiterated a Outperform rating on Varonis Systems, Inc. (NASDAQ:VRNS) on June 24, 2026. Market Context Varonis Systems, Inc.
Read moreRating Change Mizuho analysts downgraded Apogee Therapeutics, Inc. (NASDAQ:APGE) from Outperform to Neutral on June 24, 2026. Market Context Apogee Therapeutics, Inc.
Read moreRating Change Guggenheim analysts downgraded Apogee Therapeutics, Inc. (NASDAQ:APGE) from Buy to Neutral on June 24, 2026. Market Context Apogee Therapeutics, Inc.
Read moreRating Change TD Cowen analysts downgraded Apogee Therapeutics, Inc. (NASDAQ:APGE) from Buy to Hold on June 24, 2026. Market Context Apogee Therapeutics, Inc.
Read moreRating Change Stifel analysts downgraded Apogee Therapeutics, Inc. (NASDAQ:APGE) from Buy to Hold on June 24, 2026. Market Context Apogee Therapeutics, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Hinge Health, Inc. (NYSE:HNGE) on June 24, 2026. Market Context Hinge Health, Inc.
Read moreRating Change Canaccord Genuity analysts initiated coverage on Harbour Energy plc (OTC:HBRIY) with a Buy rating on June 24, 2026. Market Context Harbour Energy plc operates in the…
Read moreRating Change B of A Securities analysts reiterated a Neutral rating on The New York Times Company (NYSE:NYT) on June 24, 2026. Market Context The New York Times Company operates…
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on Exelixis, Inc. (NASDAQ:EXEL) on June 24, 2026. Market Context Exelixis, Inc.
Read moreRating Change Keybanc analysts upgraded Nucor Corporation (NYSE:NUE) from Sector Weight to Overweight on June 24, 2026. Market Context Nucor Corporation operates in the Basic…
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Prudential Financial, Inc. (NYSE:PRU) on June 24, 2026. Market Context Prudential Financial, Inc.
Read more
